Anika Therapeutics Inc at UBS Global Healthcare Conference (Virtual) Transcript
Good morning, and thank you for coming to the 2020 Virtual UBS Global Healthcare Conference. My name is Mallet Njonkem, and I'm happy to be your host for this session. Our next presenter will be Dr. Cheryl Blanchard, President and CEO; and Sylvia Cheung, Chief Financial Officer from Anika Therapeutics.
A Q&A session will follow immediately after the presentation. (Operator Instructions)
We now turn it over to Cheryl and Sylvia. Thank you.
Thank you, Mallet. Good morning, everybody. I'd like to thank the UBS team for giving us the opportunity to present today, and I'd also like to thank everybody on the line listening in for your interest in Anika. I'm Cheryl Blanchard, Anika's President and CEO; and with me on the call today is our CFO, Sylvia Cheung, and we're both very excited to speak with you today about Anika.
So if we want to look at Slide 2, I'm going to just sort of walk everybody through the slides today, so we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |